221 related articles for article (PubMed ID: 1838043)
1. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.
Winocour PH; Bhatnagar D; Ishola M; Arrol S; Durrington PN
Diabet Med; 1991 Dec; 8(10):922-7. PubMed ID: 1838043
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.
Winocour PH; Durrington PN; Bhatnagar D; Mbewu AD; Ishola M; Mackness M; Arrol S
Diabetes Res Clin Pract; 1992 Dec; 18(3):173-84. PubMed ID: 1289018
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
[TBL] [Abstract][Full Text] [Related]
5. Raised serum apolipoprotein (a) in active diabetic retinopathy.
Maioli M; Tonolo G; Pacifico A; Ciccarese M; Brizzi P; Kohner EM; Porta M
Diabetologia; 1993 Jan; 36(1):88-90. PubMed ID: 8436260
[TBL] [Abstract][Full Text] [Related]
6. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
[TBL] [Abstract][Full Text] [Related]
7. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.
Reverter JL; Sentí M; Rubiés-Prat J; Lucas A; Salinas I; Pizarro E; Pedro-Botet J; Romero R; Sanmartí A
Diabetes Care; 1994 Mar; 17(3):189-94. PubMed ID: 8174446
[TBL] [Abstract][Full Text] [Related]
8. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
Davies L; Fulcher GR; Atkins A; Frumar K; Monaghan J; Stokes G; Clifton-Bligh P; McElduff A; Robinson B; Stiel J; Twigg S; Wilmshurst E
J Diabetes Complications; 1999; 13(1):45-51. PubMed ID: 10232709
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
[TBL] [Abstract][Full Text] [Related]
10. Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes.
O'Brien SF; Watts GF; Powrie JK; Shaw KM; Miller NJ
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):81-90. PubMed ID: 8803485
[TBL] [Abstract][Full Text] [Related]
11. Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria.
Kodama T; Tomiyama T; Ishizaki T; Baba T
J Diabetes Complications; 1992; 6(2):70-6. PubMed ID: 1611142
[TBL] [Abstract][Full Text] [Related]
12. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K
Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864
[TBL] [Abstract][Full Text] [Related]
13. Serum lipids and lipoproteins in insulin-dependent diabetic patients with persistent microalbuminuria.
Watts GF; Naumova R; Slavin BM; Morris RW; Houlston R; Kubal C; Shaw KM
Diabet Med; 1989; 6(1):25-30. PubMed ID: 2522370
[TBL] [Abstract][Full Text] [Related]
14. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
Hadjadj S; Duly-Bouhanick B; Bekherraz A; BrIdoux F; Gallois Y; Mauco G; Ebran J; Marre M
Diabetes Metab; 2004 Feb; 30(1):43-51. PubMed ID: 15029097
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
[TBL] [Abstract][Full Text] [Related]
17. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria.
Dullaart RP; Dikkeschei LD; Doorenbos H
Diabetologia; 1989 Sep; 32(9):685-9. PubMed ID: 2507381
[TBL] [Abstract][Full Text] [Related]
18. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
[TBL] [Abstract][Full Text] [Related]
20. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
